(Q34982933)

5 August 2017

1 reference

title

Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances (English)

1 reference

5 August 2017

Corleto VD

1

1 reference

5 August 2017

Delle Fave G

series ordinal

2

1 reference

5 August 2017

Jensen RT

series ordinal

3

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Digestive and Liver Disease

5 August 2017

published in

1 reference

5 August 2017

volume

34

1 reference

5 August 2017

issue

9

1 reference

5 August 2017

page(s)

668-680

1 reference

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Natural history of neuroendocrine enteropancreatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Oncoprotein immunoreactivity in human endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Growth characteristics of rectal carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Her-2/neu and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

The HER-2/neu oncogene in tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Herceptin (trastuzamab) in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Genomic imbalances in the progression of endocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Chromosomal alterations in human pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Cooperative tumorigenic effects of germline mutations in Rb and p53

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Loss of heterozygosity on chromosome 11 in sporadic gastrinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Chromosome 18 deletions are common events in classical midgut carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Pancreatic endocrine tumors: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Role of disease-causing genes in sporadic pancreatic endocrine tumors:MEN1andVHL

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Multiple endocrine neoplasia type 1: clinical and genetic topics

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Lack of MEN1 gene mutations in 27 sporadic insulinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Low frequency of p16(INK4a) alterations in insulinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Insulin-like growth factor-II in endocrine pancreatic tumours. Immunohistochemical, biochemical and in situ hybridization findings

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Presence of IGF-I in human midgut carcinoid tumours--an autocrine regulator of carcinoid tumour growth?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Immunocytochemical evidence for the presence of IGF‐I and IGF‐I receptors in human endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Transforming growth factor-alpha in normal and neoplastic human endocrine tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Influence of growth factors on an insulin-producing cell line (RINm5F)

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

IGF-II-like immunoreactivity in human tissues, neuroendocrine tumors, and PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Anomalous overexpression of p27(Kip1) in sporadic pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Clonality analysis of multifocal carcinoid tumours of the small intestine by X-chromosome inactivation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

p53 and proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Absence of overexpression of p53 protein by intestinal carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Expression of p53 protein in colorectal carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Foregut carcinoids: a clinical and biochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

Prognostic variables in patients with gastrointestinal carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980212-2

7 January 2021

10.1016/S1590-8658(02)80212-2

Identifiers

DOI

1 reference

5 August 2017

1 reference